1233860-29-1

Basic information

• Product Name: (R)-tert-Butyl 3-(4-nitrophenoxy)pyrrolidine-1-carboxylate
• Synonyms: (R)-tert-Butyl 3-(4-nitrophenoxy)pyrrolidine-1-carboxylate
• CAS NO: 1233860-29-1
• Molecular Formula: C15H20N2O5
• Molecular Weight: 308.3297
• Mol File: 1233860-29-1.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (R)-tert-Butyl 3-(4-nitrophenoxy)pyrrolidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-tert-Butyl 3-(4-nitrophenoxy)pyrrolidine-1-carboxylate(1233860-29-1)
• EPA Substance Registry System: (R)-tert-Butyl 3-(4-nitrophenoxy)pyrrolidine-1-carboxylate(1233860-29-1)

Safety Data

• Hazardous Substances Data: 1233860-29-1(Hazardous Substances Data)

Upstream product

• 350-46-9 4-Fluoronitrobenzene 
• 101469-92-5 (S)-3-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 100-02-7 4-nitro-phenol 
• 139986-03-1 1,1-dimethylethyl-3(R)-{[(4-methylphenyl)sulphonyl]oxy}-1-pyrrolidinecarboxylate 
• 109431-87-0 (R)-tert-butyl 3-hydroxypyrrolidine-1-carboxylate 

Downstream Products

• 1299487-23-2 1,1,1,3,3,3-hexafluoro-2-(4-((3-(4-nitrophenoxy)pyrrolidin-1-yl)methyl)phenyl)propan-2-ol 
• 1286207-30-4 (S)-3-(4-nitrophenoxy)pyrrolidine hydrochloride 
• 1085838-95-4 (S)-3-{4-[(2-phenyl-5-trifluoromethyl-oxazole-4-carbonyl)-amino]-phenoxy}-pyrrolidine-1-carboxylic acid tert butyl ester 
• 1229419-15-1 4-((S)-3-{4-[(2-phenyl-5-trifluoromethyl-oxazole-4-carbonyl)-amino]-phenoxy}-pyrrolidin-1-yl)-benzoic acid 
• 1229419-53-7 4-((S)-3-{4-[(2-phenyl-5-trifluoromethyl-oxazole-4-carbonyl)-amino]-phenoxy}-pyrrolidin-1-yl)-benzoic acid tert-butyl ester 
• 1229419-42-4 2-phenyl-5-trifluoromethyl-oxazole-4-carboxylic acid [4-((S)-pyrrolidin-3-yloxy)-phenyl]-amide hydrochloride 

Relevant articles and documents

NAMPT inhibitors

Disclosed are compounds which inhibit the activity of NAMPT, compositions containing the compounds and methods of treating diseases during which NAMPT is expressed.

INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful

NEW COMPOUNDS

The present invention encompassescompounds of general formula (1) wherein R1 to R4 , X and n are defined as in claim 1, which are suitable for the treatment of ailments characterised byexcessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.